Catalyst Wire Dossier Catalyst Wire Dossier

BI 113823 PiB and Tablet

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 113823 PiB and Tablet, covering 2014-10-09 to 2014-10-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers [Phase 1]

See pricing